baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

JP Morgan Put 160 R66 20.06.2025/ DE000JK4RHA7 /

20/06/2024 08:57:06	Chg.-	Bid22:00:40	Ask22:00:40	Underlying	Strike price	Expiration date	Option type
3.30EUR	-	- Bid Size: -	- Ask Size: -	PHILLIPS 66 D...	160.00 -	20/06/2025	Put

GlobeNewswire 01/07 Phillips Edison & Company Announces Appointment of Devin Murphy to Board of Directors

GlobeNewswire 27/06 Entero Therapeutics Announces Peer-Reviewed Publication Unveiling Novel Algorithm for Measuring Inte...

GlobeNewswire 26/06 Almaden Announces Results of Annual General Meeting

GlobeNewswire 25/06 FibroBiologics Announces Preliminary Proof of Concept for Novel Artificial Thymus Organoid Technolog...

GlobeNewswire 21/06 Lifetime Brands, Inc. Announces Results of 2024 Annual Meeting

GlobeNewswire 20/06 The International Food Information Council (IFIC) Releases Annual Food & Health Survey Revealing Ris...

GlobeNewswire 18/06 EyePoint Pharmaceuticals to Host R&D Day on June 26, 2024

GlobeNewswire 17/06 Phillips Edison & Company Inc. Invites You to Join Its Second Quarter 2024 Earnings Conference Call

GlobeNewswire 17/06 EyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

GlobeNewswire 13/06 Rygen Technologies Launches Next-Gen Supply Chain Solution: AI-enabled TMS

GlobeNewswire 13/06 FibroBiologics Set to Join Russell 2000® Index

GlobeNewswire 12/06 Greystone Closes $22.9 Million in Total Debt Placement and Preferred Equity Financing for Fort Worth...

GlobeNewswire 06/06 FibroBiologics to Present at Extracellular Matrix Pharmacology Congress 2024

GlobeNewswire 05/06 EyePoint Pharmaceuticals to Present at Goldman Sachs 45th Annual Global Healthcare Conference

GlobeNewswire 30/05 Celebrate Life’s Sweet Surprises in New Children’s Book THE ICE CREAM TREE

GlobeNewswire 29/05 Phillips Edison & Company to Present at Nareit REITweek 2024 Investor Conference

GlobeNewswire 22/05 Entero Therapeutics to Present Corporate Update at 2024 BIO International Convention

GlobeNewswire 20/05 Entero Therapeutics Presents Two Posters on Celiac Disease Research at the 2024 Digestive Disease We...

GlobeNewswire 16/05 Optimal Daily Dairy Consumption Remains Elusive Despite Well-Established Health Benefits

GlobeNewswire 16/05 First Wave BioPharma Changes Name to Entero Therapeutics

GlobeNewswire 16/05 EyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

GlobeNewswire 15/05 FibroBiologics Announces 2024 Annual Meeting of Stockholders

Newsfile Corp 15/05 King Fuels Announces Strategic Expansion of Its Fuel Distribution Network in Texas, Colorado, Kansas...

GlobeNewswire 14/05 FibroBiologics Files 2024 First Quarter Report

GlobeNewswire 14/05 Kontrolmatik Technologies and Pomega Standardize Operations With Siemens Solutions and Form an Engin...

JP Morgan Put 160 R66 20.06.2025/ DE000JK4RHA7 /

If you wish to receive reply to your feedback, please provide your email address.